The science of frankincense

Johnson and colleagues collected resin from 12 individual Boswellia frereana trees in Somaliland. They analysed hydrodistilled essential oils from all 12 trees and dichloromethane extracts from seven. Lupeol, α-amyrin, 3-epi-lupeol and β-amyrin were prominent triterpenoids in the solvent extracts.

The essential oils also varied substantially: α-thujene ranged from 14.5–43.9% and α-pinene from 3.0–63.0%. Despite this variation, the authors described one variable essential-oil chemotype. No methoxyalkanes were detected in the tested samples.

Hamm and colleagues compared six botanically certified olibanum samples: two identified as Boswellia carteri, and one each as Boswellia sacra, Boswellia frereana, Boswellia papyrifera and Boswellia serrata. Headspace solid-phase microextraction and gas chromatography–mass spectrometry characterised their volatile and semi-volatile mono-, sesqui- and diterpenes.

The resulting profiles provided chemical identification criteria for the resins. The researchers applied these fingerprints to market frankincense, traditional incense mixtures and an archaeological frankincense sample, connecting analytical chemistry with the botanical identification of traded materials.

Blain, Ali and Duance exposed articular-cartilage explants to interleukin-1α (5 ng/mL) and oncostatin M (10 ng/mL) for 28 days. Adding Boswellia frereana extract at 100 μg/mL inhibited breakdown of the collagenous matrix.

The extract reduced MMP9 and MMP13 messenger RNA and inhibited MMP9 expression and activation. Nitrite, prostaglandin E₂ and cyclooxygenase-2 production were also significantly reduced. These results connect preservation of the cartilage matrix with reduced matrix-metalloproteinase activity and inflammatory-mediator production in the explant model.

Chemical analysis identified epi-lupeol as the principal constituent of the tested extract. The biological experiments examined the extract as a whole.

Parr and Ali treated the human triple-negative breast-cancer cell lines BT549 and MDA-MB-231 with hepatocyte growth factor (HGF, 10 ng/mL) and Boswellia frereana ethanol extract (10 μg/mL). The extract suppressed HGF-stimulated migration, invasion and cell–matrix adhesion, while reducing phosphorylation of the c-Met receptor at Tyr1234/1235.

In BT549 cells, the mean invasion count fell from 23.5 ± 6.1 with HGF alone to 13.9 ± 4.3 with HGF plus extract (p = 0.001). In MDA-MB-231 cells, the corresponding values were 65.8 ± 26.2 and 36.2 ± 17.7 (p = 0.001). BT549 migration over six hours also decreased significantly relative to HGF alone (p = 0.0056).

At the selected 10 μg/mL concentration, cell viability was retained and proliferation was not significantly altered. A separate endothelial-cell assay showed reduced HGF-stimulated tubule formation. Together, the experiments identify changes in c-Met signalling and HGF-driven cell behaviour at a non-cytotoxic extract concentration.

Yang and colleagues found that orally administered (−)-α-pinene shortened sleep latency and increased non-REM sleep duration in mice, without changing REM sleep duration or non-REM delta activity.

In hippocampal CA1 neurons, the compound prolonged GABAₐ-receptor-mediated spontaneous inhibitory postsynaptic currents. Flumazenil antagonised both the sleep and electrophysiological effects. Molecular docking supported an interaction at the benzodiazepine-binding site, consistent with the pharmacological results.

Satou and colleagues exposed mice to α-pinene by inhalation for 90 minutes per day over one, three or five days. Elevated-plus-maze testing showed anxiolytic-like activity that persisted across the five-day exposure period.

Measured α-pinene concentrations in the brain and liver peaked on day three. This experiment linked repeated inhalation with behavioural changes and tissue distribution; its endpoints were anxiety-related behaviour and compound accumulation.

Aragão and colleagues tested a mixture of α- and β-amyrin isolated from Protium heptaphyllum resin. At 10–50 mg/kg, the mixture produced sedative and anxiolytic-like effects and prolonged pentobarbital-induced sleeping time in mice.

Flumazenil reversed the open-field and elevated-plus-maze effects, supporting involvement of benzodiazepine-sensitive signalling. In a separate forced-swimming experiment, lower-dose antidepressant-like effects were blocked by reserpine; the authors proposed noradrenergic involvement for that endpoint.

Jeon and colleagues compared α-amyrin and β-amyrin in a mouse pentobarbital-induced sleep model. β-Amyrin at 1, 3 or 10 mg/kg shortened sleep onset and prolonged sleep duration; α-amyrin did not produce the same effects.

Bicuculline, a GABAₐ receptor antagonist, blocked the β-amyrin effects, and brain GABA levels increased after treatment. The results identify GABAergic involvement in β-amyrin’s potentiation of induced sleep and distinguish the activity of the two amyrin isomers.

Stengler and colleagues compared extracts of Boswellia frereana, Boswellia serrata, Boswellia neglecta, Boswellia rivae and Boswellia sacra, alongside Commiphora myrrha, Commiphora confusa and Commiphora kataf. Human airway-cell experiments included air–liquid-interface cultivation, viral-mimicry stimulation and lipopolysaccharide (LPS) stimulation, using non-cytotoxic extract concentrations.

The published abstract reports that Boswellia serrata produced the strongest inhibition of pro-inflammatory cytokines in the viral-mimicry model. In the LPS model, Commiphora myrrha increased IL-10 and inhibited IL-8. These species-specific findings establish different responses across the tested resins.

Huang and colleagues reviewed the chemical composition, pharmacological effects, pharmacokinetics and quality control of Boswellia carterii. The review catalogues volatile oils and terpenes, including boswellic and lupeolic acids, cembrane-type diterpenes, incensole and incensole acetate.

Its anti-inflammatory evidence includes aqueous-acetone resin extract in adjuvant-induced arthritis in Lewis rats: arthritic scores and paw oedema decreased, alongside reduced TNF-α and IL-1β expression. The review also brings together antioxidant assays and antitumour cell experiments. The studies below trace specific signalling and neurological findings to their original papers.

Moussaieff and colleagues investigated incensole acetate in inflammatory-signalling experiments. In TNF-α-stimulated HeLa cells, it inhibited TAK/TAB-mediated phosphorylation of the IKK activation loop and downstream NF-κB activation. The compound acted on activation of the pathway rather than directly inhibiting IKK enzyme activity in vitro.

Anti-inflammatory activity was also observed in a mouse inflamed-paw model. The study identifies a signalling mechanism connecting incensole acetate with reduced NF-κB activation.

Incensole acetate activated TRPV3 channels in transfected HEK293 cells. In behavioural testing, it produced anxiolytic- and antidepressant-like effects in wild-type mice, but not in TRPV3-knockout mice.

The comparison between wild-type and knockout animals provides experimental evidence that TRPV3 mediates these behavioural effects. This pathway is distinct from the GABA-related mechanisms investigated for α-pinene and β-amyrin.

In mice subjected to closed-head injury, incensole acetate reduced glial activation and expression of inflammatory mediators, limited hippocampal neurodegeneration and improved neurological and object-recognition outcomes.

The experiments connect reduced post-injury neuroinflammation with improved functional outcomes in this traumatic-brain-injury model.

Moussaieff and colleagues administered incensole acetate after cerebral ischemia in mice. Treatment reduced infarct volume, improved neurological function and reduced inflammatory signalling.

The experiments supported a treatment window of up to six hours after ischemia and partial mediation through TRPV3. These findings extend the compound’s mechanistic research to a second experimental model of brain injury.